中外医学研究
中外醫學研究
중외의학연구
CHINESE AND FOREIGN MEDICAL RESEARCH
2015年
13期
15-16
,共2页
中西医结合%慢性肾病
中西醫結閤%慢性腎病
중서의결합%만성신병
Integrated traditional Chinese and Western medicine%Chronic kidney disease
目的：探讨中西医结合治疗慢性肾病的疗效。方法：将2010年11月-2013年11月笔者所在医院收治的58例脾肾气虚型慢性肾病患者按照随机数字表法分组，每组29例，其中对照组实施纯西医(抗生素、降压和利尿等)治疗，观察组实施中西医结合治疗，对两组患者治疗3个月后的状况进行分析和比较。结果：治疗3个月后总有效率、并发症发生率，观察组分别为93.1%(27/29)和0(0/29)，对照组为65.5%(19/29)和24.1%(7/29)，两组比较差异均有统计学意义(P<0.05)。结论：脾肾气虚型慢性肾病患者应用中西医结合治疗，疗效显著、安全，临床应用价值相对较高，建议进一步推广。
目的：探討中西醫結閤治療慢性腎病的療效。方法：將2010年11月-2013年11月筆者所在醫院收治的58例脾腎氣虛型慢性腎病患者按照隨機數字錶法分組，每組29例，其中對照組實施純西醫(抗生素、降壓和利尿等)治療，觀察組實施中西醫結閤治療，對兩組患者治療3箇月後的狀況進行分析和比較。結果：治療3箇月後總有效率、併髮癥髮生率，觀察組分彆為93.1%(27/29)和0(0/29)，對照組為65.5%(19/29)和24.1%(7/29)，兩組比較差異均有統計學意義(P<0.05)。結論：脾腎氣虛型慢性腎病患者應用中西醫結閤治療，療效顯著、安全，臨床應用價值相對較高，建議進一步推廣。
목적：탐토중서의결합치료만성신병적료효。방법：장2010년11월-2013년11월필자소재의원수치적58례비신기허형만성신병환자안조수궤수자표법분조，매조29례，기중대조조실시순서의(항생소、강압화이뇨등)치료，관찰조실시중서의결합치료，대량조환자치료3개월후적상황진행분석화비교。결과：치료3개월후총유효솔、병발증발생솔，관찰조분별위93.1%(27/29)화0(0/29)，대조조위65.5%(19/29)화24.1%(7/29)，량조비교차이균유통계학의의(P<0.05)。결론：비신기허형만성신병환자응용중서의결합치료，료효현저、안전，림상응용개치상대교고，건의진일보추엄。
Objective:To investigate the effect of integrated traditional Chinese and Western medicine in the treatment of chronic kidney disease. Method:58 cases dysfunction of spleen and kidney of chronic kidney disease from November 2010 to November 2013 in our hospital were randomly divided into two groups,29 cases in each group.The control group was treated with western medicine(antibiotics,drop pressure and diuretic),and the observation group were treated with Integrated traditional Chinese and Western medicine.The situation after 3 months treatment of two groups were analyzed and compared.Result:After three months treatment,the total efficiency and the complication rate of the observation group were 93.1%(27/29) and 0(0/29),the control group were 65.5%(19/29) and 24.1%(7/29).The differences between the two groups were statistically significant(P<0.05). Conclusion:The patients with chronic kidney disease of spleen qi deficiency syndrome should be treated by integrative medicine.The effect is significant and safety and the clinical value is relatively high,so it is recommended to further promote.
